Self Protection from Anti-Viral Responses – Ro52 Promotes Degradation of the Transcription Factor IRF7 Downstream of the Viral Toll-Like Receptors

• Rowan Higgs,

  Affiliation Molecular and Cellular Therapeutics and RSCI Research Institute, Royal College of Surgeons in Ireland, Dublin, Ireland

  ⨯
• Elisa Lazzari,

  Affiliation Molecular and Cellular Therapeutics and RSCI Research Institute, Royal College of Surgeons in Ireland, Dublin, Ireland

  ⨯
• Claire Wynne,

  Affiliation Molecular and Cellular Therapeutics and RSCI Research Institute, Royal College of Surgeons in Ireland, Dublin, Ireland

  ⨯
• Joan Ní Gabhann,

  Affiliation Molecular and Cellular Therapeutics and RSCI Research Institute, Royal College of Surgeons in Ireland, Dublin, Ireland

  ⨯
• Alexander Espinosa,

  Affiliation Department of Medicine, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Marie Wahren-Herlenius,

  Affiliation Department of Medicine, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Caroline A. Jefferies

  * E-mail: cjefferies@rcsi.ie

  Affiliation Molecular and Cellular Therapeutics and RSCI Research Institute, Royal College of Surgeons in Ireland, Dublin, Ireland

  ⨯